GlaxoSmithKline (GSK) and Pfizer Inc. (PFE) Says Future IPO Possible For ViiV Healthcare  
11/10/2010 6:42:49 AM

NEW YORK Nov 9 (Reuters) - An HIV company set up a year ago by GlaxoSmithKline Plc (GSK.L) and Pfizer Inc (PFE.N) could be spun off and floated in an initial public offering once its drug pipeline has matured a little further.